Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.

By P. Stackelberg, E. Furlong, M. Meyer, S. Zaugg, A. Henderson, Dori B. Reissman. Science of the Total Environment, 2004

1,069 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Contamination of surface, ground, and drinking water from pharmaceutical production (2009, background): “Direct exposure to pharmaceuticals at levels normally found in drinking water (up to 100 ng/L) is generally not considered to pose human health risks [23–25].”
The effects of the surface oxidation of activated carbon, the solution pH and the temperature on adsorption of ibuprofen (2013, background): “[4] Stackelberg PE, Furlong ET, Meyer MT, Zaugg SD, Henderson AK, Reissman DB.”
A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. (2014, background): “Furthermore, drinking water treatment plays a significant role in eliminating micropollutants from drinking water and has therefore been comprehensively examined (Stackelberg et al., 2004; Westerhoff et al., 2005).”
Ecotoxicology of human pharmaceuticals. (2006, background): “Some drinking waters (Heberer and Stan, 1996; tumpf et al., 1999; Putschew et al., 2000; Zuccato t al., 2000; Stackelberg et al., 2004), groundwaters Holm et al.”
Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. (2009, neutral): “Antiasthmatic Albuterol Stackelberg et al. (2004) 1”